Innova Biosciences adds ALEXA Fluor 488 to Lightning-Link range of antibody labeling kits

Using secondary antibodies for fluorescent detection based applications is commonly associated with issues such as high background fluorescence and non-specific binding. The addition of the ALEXA Fluor 488 label to Lightning-Link kits now enables easy, direct conjugation of the label to primary antibodies.

Lightning-Link allows for conjugation of antibodies and proteins in less than 20 minutes, using a very simple protocol which is free of separation steps, saving researchers time and precious materials. Researchers also have the flexibility to label from as little as 10µg of their antibody to hundreds of milligrams. Alternative direct antibody labeling kits on the market for ALEXA Fluor 488 involve multiple steps and require far longer set-up and incubation times.

Nick Gee, CEO and CSO at Innova Biosciences, commented: “We are excited to be able to offer researchers access to ALEXA Fluor 488 in our Lightning-Link format, the World’s easiest-to-use primary antibody labeling technology. Innova Biosciences is committed to developing solutions that simplify processes and increase efficiency in the lab, and this new kit will make a huge difference to many researchers.”

For more information please visit: https://www.innovabiosciences.com/rapid-antibody-and-protein-labeling-kits/lightning-link-rapid-alexa-fluor-488.html

ALEXA Fluor® is a trademark of Life Technologies Corporation.


 

About Innova Biosciences Limited

Innova Biosciences are world leading experts in easy-to-use, cutting-edge bioconjugation technologies and services. The Company has the flexibility to support scientists from academia through to commercial manufacturing, developing and supplying reagent products to make science easier, both off-the shelf and to customer specification. Innova’s products are based on its antibody and protein labelling technology, nanoparticle and oligonucleotide labelling and phosphate detection enzyme assay technologies.

All of Innova Biosciences’ product ranges are of the highest quality and are designed to streamline R&D and manufacturing processes, whilst also reducing overall project costs by cutting expenses associated with e.g. material waste, in-house equipment and staff time, providing increased return on investment compared to traditional methods.

Innova Biosciences’ ever expanding portfolio, including the Lightning-Link®, InnovaCoat® and Thunder-Link® brands, is available to research laboratories, pharmaceutical, biotechnology and diagnostic companies worldwide.

Innova Biosciences is a privately held company and was founded in 2002.

*******

Media contact
Katie Odgaard, Zyme Communications
Email: katie.odgaard@zymecommunications.com
Phone: +44 (0)7787 502 947
_____________________________________________________________